| [1] | Holmes J,Stanko J,Varchenko M,et al. Comparative neurotoxicity of oxaliplatin,cisplatin,and ormaplatin in a Wistar rat model[J].Toxicol Sci,1998,46(2):342－351. |
| [2] Grolleau F,Gamelin L,Boisdron-Celle M,et al. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels[J]. J Neurophysiol,2001,85 (5):2293－2297. | |
| [3] Webster RG,Brain KL,Wilson RH,et al. Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels[J]. Br J Pharmacol,2005,146(7):1027－1039. | |
| [4] Gamelin L,Boisdron-Celle M,Delva R,et al. Prevention of oxaliplatin-related neurotoxicity by calcium and | |
| [5] | magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer[J]. Clin Cancer Res,2004,10(12):4055－4061. |
| [5] Armstrong CM,Cota G. Calcium block of Na+ channels and its effect on closing rate[J]. Proc Natl Acad Sci U S A,1999,96(7):4154－4157. | |
| [6] Adelsberger H,Quasthoff S,Grosskreutz J,et al. The chemotherapeutic oxaliplatin alters voltage-gated Na( +) channel kinetics on rat sensory neurons[J]. Eur J Pharmacol,2000,406(1):25－32. | |
| [7] Lajer H,Daugaard G. Cisplatin and hypomagnesemia[J]. Cancer Treat Rev,1999,25(1):47－58. | |
| [8] Hochster HS,Grothey A,Childs B,et al. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity[J]. J Clin Oncol,2007,25(25):4028－4029. | |
| [9] Grothey A,Nikcevich DA,Sloan JA,et al. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer:NCCTG N04C7[J]. J Clin Oncol,2011,29(4):421－427. | |
| [10] 姜雅秋,刘国良,王秋月. 弥可保治疗糖尿病周围神经病变的疗效观察[J]. 辽宁医学杂志,1998,12(2):100－101. |